Navigation Links
Statement by UHW President Sal Rosselli on SEIU Threat to Sue UHW Leaders
Date:4/29/2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 2Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 2Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 4Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 5Frost 26amp 3B Sullivan Recognizes Fovia for its HDVR 28R 29 Platform A Disruptive Technology Breakthrough 6205 1Frost 26amp 3B Sullivan Recognizes Fovia for its HDVR 28R 29 Platform A Disruptive Technology Breakthrough 6205 2Frost 26amp 3B Sullivan Recognizes Fovia for its HDVR 28R 29 Platform A Disruptive Technology Breakthrough 6205 3Frost 26amp 3B Sullivan Recognizes Fovia for its HDVR 28R 29 Platform A Disruptive Technology Breakthrough 6205 4Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings 6201 1Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings 6201 2Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings 6201 3Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 1Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 2Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 3Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 4Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 5Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 6